U.S. Pharmaceuticals & Biotech Nano Cap Stocks

aTyr Pharma

Market Cap: US$46.6m

A clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.

Talphera

Market Cap: US$43.1m

A specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings.

Gossamer Bio

Market Cap: US$41.6m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States.

RenovoRx

Market Cap: US$39.0m

A clinical-stage biopharmaceutical company, engages in developing targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment.

Grace Therapeutics

Market Cap: US$35.6m

Engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.

BioXcel Therapeutics

Market Cap: US$34.3m

Together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States.

Actinium Pharmaceuticals

Market Cap: US$32.6m

Develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies.

MDxHealth

Market Cap: US$30.1m

A commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally.

Bioqual

Market Cap: US$29.1m

Provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States.

MariMed

Market Cap: US$27.2m

Engages in cultivation, production, and selling of branded cannabis products in the United States.

Dyadic International

Market Cap: US$24.9m

A biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States.

TherapeuticsMD

Market Cap: US$21.1m

Operates as a pharmaceutical royalty company in the United States and internationally.

Traws Pharma

Market Cap: US$19.2m

A clinical-stage biopharmaceutical company, develops small synthetic molecules for respiratory viral diseases and cancer.

Cellectar Biosciences

Market Cap: US$18.0m

A clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States.

Bio Essence

Market Cap: US$13.6m

Engages in manufacturing and distributing health supplement products.

Jasper Therapeutics

Market Cap: US$13.0m

A clinical-stage biotechnology company, focuses on developing therapeutics targeting mast stem cell driven diseases in the United States.

Pharma-Bio Serv

Market Cap: US$11.2m

Operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.

Biofrontera

Market Cap: US$10.6m

A biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

CordovaCann

Market Cap: US$1.5m

Engages in the provision of services and investment capital to the processing, production, and retail vertical markets of the cannabis industry in Canada and United States.

Sunset Island Group

Market Cap: US$34.4k

Through its subsidiary, VBF Brands, grows, cultivates, manufactures, and distributes cannabis in the United States.

FinCanna Capital

Market Cap: US$998.0

Does not have significant operations.